False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies
Hs. Jethwa et al., False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies, CLIN EXP IM, 121(3), 2000, pp. 544-550
Anti-myeloperoxidase antibodies (anti-MPO) are a major type of anti-neutrop
hil cytoplasmic antibody (ANCA). While evaluating anti-MPO monoclonal antib
odies from SCG/Kj mice, we observed several hybridomas that appeared to rea
ct with both MPO and DNA. Sera from some patients with systemic lupus eryth
ematosus (SLE) also react with MPO and DNA. We hypothesized that the MPO bi
nding activity is a false-positive result due to the binding of DNA, contai
ned within the antigen binding site of anti-DNA antibodies, to the cationic
MPO. Antibodies from tissue culture supernatants from 'dual reactive' hybr
idomas were purified under high-salt conditions (3 m NaCl) to remove any an
tigen bound to antibody. The MPO and DNA binding activity were measured by
ELISA. The MPO binding activity was completely abrogated while the DNA bind
ing activity remained. The MPO binding activity was restored, in a dose-dep
endent manner, by the addition of increasing amount of calf-thymus DNA (CT-
DNA) to the purified antibody. Sera from six patients with SLE that reacted
with both MPO and DNA were treated with DNase and showed a decrease in MPO
binding activity compared with untreated samples. MPO binding activity was
observed when CT-DNA was added to sera from SLE patients that initially re
acted with DNA but not with MPO. These results suggest that the DNA contain
ed within the antigen binding site of anti-DNA antibodies could bind to the
highly cationic MPO used as substrate antigen in immunoassays, resulting i
n a false-positive test.